Accordingly, the present study was designed as a pilot investigation aimed at comparing serum miRNA-223-3p and IL-1β expression levels, along with VAS scores, between fibromyalgia patients and healthy individuals. The gene discussed is IL1B; the disease is fibromyalgia.